Manulife (Manufacturers Life Insurance)’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-39,386
Closed -$120K 3019
2024
Q4
$120K Sell
39,386
-1,299
-3% -$3.95K ﹤0.01% 2782
2024
Q3
$211K Sell
40,685
-1,611
-4% -$8.36K ﹤0.01% 2645
2024
Q2
$109K Buy
42,296
+9,601
+29% +$24.7K ﹤0.01% 2802
2024
Q1
$161K Sell
32,695
-7,525
-19% -$37K ﹤0.01% 2671
2023
Q4
$354K Sell
40,220
-1,352
-3% -$11.9K ﹤0.01% 2329
2023
Q3
$477K Buy
41,572
+8,260
+25% +$94.7K ﹤0.01% 2164
2023
Q2
$843K Buy
33,312
+1,635
+5% +$41.4K ﹤0.01% 1750
2023
Q1
$1.02M Buy
31,677
+1,079
+4% +$34.8K ﹤0.01% 1626
2022
Q4
$565K Buy
30,598
+3,161
+12% +$58.4K ﹤0.01% 1906
2022
Q3
$741K Sell
27,437
-493
-2% -$13.3K ﹤0.01% 1743
2022
Q2
$386K Sell
27,930
-1,133
-4% -$15.7K ﹤0.01% 2218
2022
Q1
$567K Sell
29,063
-7,916
-21% -$154K ﹤0.01% 2128
2021
Q4
$603 Buy
36,979
+511
+1% +$8 ﹤0.01% 2152
2021
Q3
$1.02M Sell
36,468
-3,007
-8% -$83.8K ﹤0.01% 1824
2021
Q2
$1.17M Buy
39,475
+3,671
+10% +$109K ﹤0.01% 1900
2021
Q1
$1M Sell
35,804
-2,029
-5% -$56.7K ﹤0.01% 1880
2020
Q4
$1.07M Buy
37,833
+2,275
+6% +$64.5K ﹤0.01% 1775
2020
Q3
$894K Buy
35,558
+1,852
+5% +$46.6K ﹤0.01% 1718
2020
Q2
$862K Buy
33,706
+2,583
+8% +$66.1K ﹤0.01% 1687
2020
Q1
$461K Buy
31,123
+4,463
+17% +$66.1K ﹤0.01% 1879
2019
Q4
$433K Sell
26,660
-1,585
-6% -$25.7K ﹤0.01% 2133
2019
Q3
$389K Sell
28,245
-23
-0.1% -$317 ﹤0.01% 2163
2019
Q2
$367K Buy
28,268
+2,691
+11% +$34.9K ﹤0.01% 2237
2019
Q1
$403K Buy
25,577
+4,879
+24% +$76.9K ﹤0.01% 2180
2018
Q4
$417K Sell
20,698
-1,493
-7% -$30.1K ﹤0.01% 2070
2018
Q3
$552K Sell
22,191
-2,578
-10% -$64.1K ﹤0.01% 2210
2018
Q2
$680K Buy
24,769
+4,323
+21% +$119K ﹤0.01% 2150
2018
Q1
$630K Buy
20,446
+2,274
+13% +$70.1K ﹤0.01% 2164
2017
Q4
$650K Buy
18,172
+234
+1% +$8.37K ﹤0.01% 2142
2017
Q3
$495K Sell
17,938
-366
-2% -$10.1K ﹤0.01% 2283
2017
Q2
$483K Buy
18,304
+1,275
+7% +$33.6K ﹤0.01% 2317
2017
Q1
$354K Buy
17,029
+2,021
+13% +$42K ﹤0.01% 2424
2016
Q4
$311K Buy
15,008
+340
+2% +$7.05K ﹤0.01% 2448
2016
Q3
$238K Sell
14,668
-252
-2% -$4.09K ﹤0.01% 2642
2016
Q2
$203K Buy
14,920
+2,500
+20% +$34K ﹤0.01% 2694
2016
Q1
$218K Buy
12,420
+1,688
+16% +$29.6K ﹤0.01% 2538
2015
Q4
$366 Buy
10,732
+210
+2% +$7 ﹤0.01% 2225
2015
Q3
$313 Buy
10,522
+140
+1% +$4 ﹤0.01% 2303
2015
Q2
$332 Buy
10,382
+3,671
+55% +$117 ﹤0.01% 2425
2015
Q1
$140 Buy
6,711
+163
+2% +$3 ﹤0.01% 2994
2014
Q4
$111 Buy
6,548
+902
+16% +$15 ﹤0.01% 3034
2014
Q3
$109 Buy
5,646
+1,200
+27% +$23 ﹤0.01% 3054
2014
Q2
$151K Buy
+4,446
New +$151K ﹤0.01% 2930